For the year ending 2025-12-31, ACET has $192,355K in assets. $33,145K in debts. $38,918K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 38,918 | |||
| Short-term investments in treasury securities | 119,612 | |||
| Prepaid expenses and other current assets | 2,396 | |||
| Total current assets | 160,926 | |||
| Restricted cash | 2,872 | |||
| Total property and equipment | 43,919 | |||
| Less accumulated depreciation and amortization | 27,387 | |||
| Property and equipment, net | 16,532 | |||
| Operating lease right-of-use asset | 10,927 | |||
| Finance lease right-of-use asset | 1,022 | |||
| Other non-current assets | 76 | |||
| Total assets | 192,355 | |||
| Accounts payable | 4,739 | |||
| Accrued and other current liabilities | 13,606 | |||
| Operating lease liability | 2,837 | |||
| Finance lease liability | 349 | |||
| Total current liabilities | 21,531 | |||
| Operating lease liability, net of current portion | 10,910 | |||
| Finance lease liability, net of current portion | 642 | |||
| Other non-current liabilities | 62 | |||
| Total liabilities | 33,145 | |||
| Common stock, 0.0001 par value, 300,000,000 shares authorized as of december 31, 2025 and december 31, 2024, respectively 9,586,770 and 5,160,545 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 10 | |||
| Additional paid-in capital | 773,795 | |||
| Accumulated deficit | -614,697 | |||
| Accumulated other comprehensive income | 102 | |||
| Total stockholders' equity | 159,210 | |||
| Total liabilities and stockholders' equity | 192,355 | |||
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc. (ACET)